SAG101 Antibody

What is SAG101 and why is it significant in plant immunity research?

SAG101 is a plant-specific protein that interacts with EDS1 to form a critical nuclear complex involved in plant immune signaling. Its significance lies in its essential role in EDS1-dependent defense responses, particularly in TIR-NB-LRR (TNL) receptor-triggered immunity. SAG101 contributes to programmed cell death triggered by TNL immune receptors and helps restrict the growth of virulent pathogens .

To study SAG101's function, researchers should consider both loss-of-function approaches (using null mutants like sag101-1 and sag101-2) and protein interaction studies to understand its relationship with other immune components. The protein's involvement in distinct spatial complexes (EDS1-SAG101 in the nucleus versus EDS1-PAD4 in both nucleus and cytoplasm) makes it particularly interesting for subcellular localization studies .

How is a SAG101 antibody typically generated for research purposes?

For generating SAG101-specific antibodies, researchers have successfully used a peptide immunization approach. This involves:

• Selecting unique SAG101 peptide sequences not found in related proteins

• Synthesizing these peptides and conjugating them to carrier proteins

• Immunizing rabbits to produce polyclonal antisera

• Purifying the resulting antibodies using affinity chromatography

As demonstrated in the literature, rabbit polyclonal antibodies raised against two unique SAG101 peptides have successfully detected a band of the expected size (~62 kD) in Arabidopsis soluble leaf extracts, confirming their specificity by absence of this band in sag101 null mutants .

What are the optimal methods for protein extraction when working with SAG101 antibodies?

For effective SAG101 protein detection using antibodies, researchers should:

• Extract total soluble protein from plant tissue (typically leaves) using a buffer containing:

  • Detergent (e.g., Triton X-100) to solubilize membrane proteins

  • Protease inhibitors to prevent degradation

  • Reducing agents to maintain protein structure

  • Appropriate pH buffering (typically around pH 7.5)

• Centrifuge samples to remove cell debris and insoluble material

• Quantify protein concentration to ensure equal loading for immunoblot analysis

This approach has been successfully employed to detect SAG101 in studies examining its accumulation and stability in various genetic backgrounds (e.g., in eds1, pad4, and pad4 sag101 mutants) .

What controls should be included when using SAG101 antibodies in immunoblotting experiments?

When conducting immunoblot experiments with SAG101 antibodies, the following controls are essential:

• Positive control: Wild-type plant extracts known to express SAG101 (e.g., Col-0 in Arabidopsis)

• Negative control: Extracts from confirmed sag101 null mutants (e.g., sag101-1 and sag101-2) to verify antibody specificity

• Loading control: Detection of a constitutively expressed protein (e.g., actin or tubulin) to normalize protein amounts across samples

• Cross-reactivity check: Testing the antibody against recombinant SAG101 protein and extracts from plants overexpressing SAG101 to confirm specificity

These controls help validate the specificity of the antibody and ensure accurate interpretation of results, particularly when examining SAG101 protein levels in different genetic backgrounds or under various treatment conditions .

How can SAG101 antibodies be used to investigate protein-protein interactions in the EDS1 defense signaling pathway?

SAG101 antibodies are valuable tools for investigating protein-protein interactions through several sophisticated approaches:

• Co-immunoprecipitation (Co-IP):

  • Use anti-SAG101 antibodies to pull down SAG101 protein complexes from plant extracts

  • Follow with immunoblotting using antibodies against potential interacting partners

  • Alternatively, use antibodies against tagged proteins (e.g., HA-EDS1) for initial pull-down, then detect SAG101 in the precipitated complex

• Reciprocal Co-IP verification:

  • Perform Co-IP in both directions (SAG101 → EDS1 and EDS1 → SAG101)

  • Compare interaction profiles under different conditions (e.g., pathogen challenge, hormone treatments)

• Subcellular fractionation coupled with Co-IP:

  • Separate nuclear and cytoplasmic fractions before performing Co-IP

  • This approach has revealed that SAG101 forms complexes with EDS1 specifically in the nucleus, distinct from EDS1-PAD4 associations found in both cellular compartments

When designing these experiments, researchers should consider that protein interactions may be transient or condition-dependent, potentially requiring crosslinking approaches or specific timing after pathogen challenge to capture biologically relevant interactions.

What methodological approaches can resolve contradictory results when studying SAG101 protein accumulation in different genetic backgrounds?

When facing contradictory results regarding SAG101 protein accumulation, researchers should implement the following methodological strategies:

• Comprehensive genetic analysis:

  • Compare SAG101 protein levels across multiple allelic variants of interacting partners

  • Include double and triple mutants (e.g., pad4-1 sag101, eds1 pad4) to assess interdependence

  • Use complementation lines to confirm phenotypes are due to specific mutations

• Transcript vs. protein analysis correlation:

  • Perform parallel RT-PCR (for mRNA levels) and immunoblot analysis (for protein levels)

  • This approach revealed that while SAG101 mRNA remains stable in eds1 mutants, the protein is severely depleted, indicating post-transcriptional regulation

• Protein stability assessment:

  • Use cycloheximide chase assays to determine protein half-life

  • Compare degradation rates in different genetic backgrounds

• Alternative detection methods:

  • Employ both N- and C-terminal tagged versions of the protein

  • Use mass spectrometry-based quantification as an antibody-independent approach

This multi-faceted approach can help distinguish between effects on transcription, translation, and protein stability, resolving apparent contradictions in experimental data .

How can SAG101 antibodies be optimized for chromatin immunoprecipitation (ChIP) experiments to study potential DNA-binding functions?

Although SAG101 itself has not been directly shown to bind DNA, its nuclear localization and association with EDS1 (which has been implicated in nucleic acid binding) suggest potential chromatin-associated functions. To optimize SAG101 antibodies for ChIP experiments:

• Antibody validation for ChIP applications:

  • Test different antibody preparations for chromatin binding efficiency

  • Perform epitope accessibility analysis (as protein-DNA interactions may mask antibody binding sites)

  • Validate using tagged SAG101 versions with parallel ChIP using anti-tag antibodies

• Crosslinking optimization:

  • Test various formaldehyde concentrations (typically 1-3%)

  • Optimize crosslinking times (typically 10-30 minutes)

  • Consider dual crosslinking approaches for enhanced detection of protein-DNA interactions

• Chromatin fragmentation protocol refinement:

  • Optimize sonication conditions for appropriate fragment size (200-500 bp)

  • Evaluate enzymatic digestion alternatives (e.g., MNase) if sonication yields inconsistent results

• Controls and validation:

  • Perform ChIP in sag101 null mutants as negative controls

  • Use known EDS1-associated genomic regions as positive controls

  • Validate findings with orthogonal approaches (e.g., DNA adenine methyltransferase identification)

These approaches can help determine if SAG101 associates with chromatin, potentially in concert with its interaction partner EDS1, which has been implicated in nucleic acid binding based on structure-function analyses of the EP domain .

What techniques can be employed to study the dynamics of EDS1-SAG101 complex formation during pathogen infection using SAG101 antibodies?

To investigate the dynamics of EDS1-SAG101 complex formation during immune responses, researchers can employ these sophisticated approaches:

• Time-course Co-IP analysis:

  • Perform Co-IP at multiple time points after pathogen challenge

  • Quantify the ratio of interacting proteins to total protein levels

  • Compare complex formation kinetics with the timing of defense gene activation

• Fluorescence-based interaction monitoring:

  • Use FRET (Fluorescence Resonance Energy Transfer) with fluorescently-tagged proteins

  • Employ FLIM (Fluorescence Lifetime Imaging Microscopy) to measure interaction dynamics in live cells

  • These approaches have successfully confirmed EDS1-SAG101 nuclear interactions

• Proteomics analysis of changing complexes:

  • Perform quantitative mass spectrometry on immunoprecipitated complexes across time points

  • Identify additional proteins that may join or leave the EDS1-SAG101 complex during immune activation

  • Compare proteomes between susceptible and resistant interactions

• Single-molecule tracking:

  • Implement super-resolution microscopy combined with photoactivatable fluorescent tags

  • Track individual complexes to determine mobility and clustering during immune responses

This multi-dimensional analysis can reveal how pathogen challenge influences the composition, abundance, and subcellular distribution of EDS1-SAG101 complexes, providing insights into the temporal regulation of immune signaling .

How can researchers accurately quantify SAG101 protein levels when studying EDS1-dependent protein stabilization mechanisms?

For precise quantification of SAG101 protein levels when investigating stabilization mechanisms:

• Quantitative immunoblotting protocol:

  • Use infrared fluorescence-based detection systems (e.g., LI-COR Odyssey) for wider linear range

  • Include calibration curves with purified recombinant SAG101 protein

  • Normalize to multiple reference proteins for robust quantification

  • Implement image analysis software with consistent quantification parameters

• Pulse-chase experiments:

  • Label newly synthesized proteins (e.g., with radioactive amino acids or non-canonical amino acid analogs)

  • Track protein stability over time in different genetic backgrounds (e.g., wild-type vs. eds1 mutants)

  • This approach can distinguish between synthesis and degradation effects

• Analysis of protein aggregation states:

  • Perform size exclusion chromatography to separate monomeric and complexed SAG101

  • Compare the stability of different protein forms

  • Determine if EDS1 primarily stabilizes monomeric or complexed SAG101

• Targeted proteomic approaches:

  • Implement selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) mass spectrometry

  • Use isotope-labeled peptide standards for absolute quantification

  • These methods provide antibody-independent validation of protein levels

These approaches have revealed that EDS1 is absolutely required for SAG101 accumulation, with SAG101 protein being severely depleted in eds1 mutants despite normal mRNA levels, indicating post-transcriptional regulation .

What are the methodological considerations for studying SAG101 in non-model plant species using cross-reactive antibodies?

When extending SAG101 research to non-model plant species using potentially cross-reactive antibodies:

• Antibody cross-reactivity assessment:

  • Perform sequence alignments of SAG101 homologs to identify conserved epitopes

  • Test antibodies against recombinant proteins from target species

  • Validate specificity using available mutants or gene silencing approaches

• Epitope conservation analysis:

  • Create a table comparing the conservation of known SAG101 epitopes across species

  • Design new antibodies targeting highly conserved regions if necessary

  • Consider using a cocktail of antibodies targeting different epitopes for robust detection

• Heterologous expression system validation:

  • Express the SAG101 homolog from the target species in a model system

  • Test antibody detection limits and specificity

  • Optimize extraction protocols for the specific plant species (considering secondary metabolites that may interfere)

• Comparative immunoprecipitation efficiency:

  • Quantify immunoprecipitation efficiency across species

  • Adjust antibody concentrations and binding conditions for optimal performance

  • Consider using tagged versions of the protein for initial studies

These methodological considerations are essential when expanding SAG101 research beyond Arabidopsis to understand the conservation of EDS1-SAG101-PAD4 immune signaling networks across plant species, especially since these genes exist in all seed plants and form a plant-specific family with conserved domains .